InternationalUSRemember you can easily switch between MIP US and MIP International at any time

How Allergan’s Mohawk tribe patent deal could blow up the IPR system

Michael Loney, New York


If successful, Allergan’s eye-catching gambit of seeking to cancel PTAB proceedings by assigning patents to the Saint Regis Mohawk Tribe would be a blueprint for others to follow. But will the PTAB rule that sovereign immunity applies in this case?

Patent Trial and Appeal Board (PTAB) practitioners will have no need for Restasis if Allergen’s brazen move to preserve patents for the dry eye treatment is successful. Instead, they’ll be crying about the end of the PTAB as we know...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @JNurt: I'm doing some research on autonomous vehicles and intellectual property, for publication later this year. If this topic is of i…

Feb 23 2018 02:07 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @IP_STARS: Here's another observation re Scotch Whisky GI dispute. Let's see what the CJEU says! https://t.co/PhmrBIX2W8

Feb 23 2018 02:04 ·  reply ·  retweet ·  favourite
ManagingIP profile

ANDA pharma litigation spikes back up in 2017 https://t.co/tApxNkPZRA After a slump in 2016, US pharmaceutical pate… https://t.co/0s7iBMfqge

Feb 22 2018 05:53 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

February 2018

FRAND aid: Is the European Commission’s SEP guidance useful?

Both patent owners and implementers have welcomed the European Commission’s communication on standard essential patents. Does that mean it has successfully balanced competing interests or merely dodged the difficult questions? James Nurton investigates



Most read articles

Supplements